A Review of Global Epidemiology and Antibiotic Resistance of Staphylococcus Aureus
Tanveer Tara, Zakirullah Khan, Hina Ali, Sadia Sardar, Abdul Samad, Karim Ullah, Waheed Urrehman, Azka Batool, Naila, Ihsan Ullah, Junaid Ahmad, Zeeshan Ahmad
3921
ABSTRACT
Background: Staphylococcus aureus is gram-positive cocci,
which causes multiple complications such as bone, skin, joint and soft tissue
infections. Penicillin was the first antibiotic that showed resistance to S.
aureus; however, following penicillin, S. aureus became resistant to
Methicillin and became a problem in many parts of the world. Worldwide
epidemiology of S. aureus varies by
country. In Austria, CA-MRSA accounts for 10% of all MRSA isolates. Many clones
of S. aureus were discovered in Asian and as well as in European countries.
Many patients in Southeast Asia are infected with various S. aureus variants.
Aim: The aim of this study was to review
epidemiology and antibiotic resistance of S. aureus in different countries.
Results: Previous findings revealed that
Panton-Valentine leukeocidin (PVL) genes were present in S. aureus strains.
Furthermore, most widely accepted antibiotic resistance genes in clinical
isolates of S. aureus strains are mecA. S. aureus spread throughout the hospital
and into the community as well. They differ from one another in some ways, such
as PVL genes and staphylococcal Chromosomal Cassette Mec (SCCmec) subtyping.
Conclusion: It is concluded based on previously published
research as well as review articles that different clones are of S. aureus are
present in different regions of the world which further shows similar
characteristics in some regions while totally different from the clones found
in other countries. S. aureus infection can be treated by combining some
antibiotics such as Vancomycin with Rifampin and Gentamicin. It can also be
avoided by practicing good hand hygiene and avoiding intravenous drugs, which
can cause a variety of infections.
Keywords:
Staphylococcus aureus, MRSA, CA-MRSA, HA-MRSA, Resistance